LOS ANGELES – Jan. 26, 2016 – Greenberg Traurig, LLP’s Rick L. Shackelford will speak at the ACI Defending Food & Beverage Consumer Fraud Litigation Summit Tuesday, Jan. 26, at the Sheraton Fisherman’s Wharf in San Francisco, California.
Shackelford will speak on the panel, “Class Certification Issues: Class Certification Rule 23(a)(2) – Commonality,” where the panelists will discuss the certification rule in regards to the Supreme Court case Tyson Foods, Inc. v. Bouaphakeo.
According to its website, the 4th annual summit will highlight continuing trends in the food-borne litigation space, including: Ascertainability and Commonality – Dissecting Class Certification Issues; How to Settle a Claim – Determining Your Best Strategy; The Battle Over Prop 65’s Fundamentals – Beech-Nut and its Backlash; and New Mislabeling Claim Trends – What’s Beyond “Natural.”
Shackelford’s practice focuses on complex litigation in numerous fields, including consumer class actions, product liability, false advertising, bankruptcy, securities, insurance, real estate, and commercial law. He has considerable experience in consumer class action litigation, having been involved in class actions in federal courts in several states. In addition, his practice includes trials and appeals, in many instances involving cases he has handled from their initial pleading stages. He has defended clients in consumer product liability cases, including Proposition 65 claims. He has also represented debtors and creditors in bankruptcy actions throughout California, as well as in Ohio, Texas, and Nevada, and has defended and prosecuted avoidance actions.
Greenberg Traurig’s Food & Beverage Group is a multidisciplinary team whose members leverage deep experience in the industry to advise clients on transactional, litigation, and regulatory matters. Transactional areas range from product development and distribution to M&A deals, commercial contracts, and distribution, as well as import and export agreements. Clients regularly turn to Greenberg Traurig to lead them through bet-the-product and bet-the-company litigation, including claims involving false advertising, consumer protection violations or class action, and intellectual property disputes. The team also assists clients in avoiding investigations or regulatory penalties from the FDA, with advice on compliance for product labeling, safety, and recalls to advertising and marketing reviews.